Improved vaccines for the control of East Coast Fever: IPSR Innovation Profile
The assessment of an experimental vaccine for the control of East Coast fever (ECF). Thelieria parva, the causative agent of ECF, is a killer parasite infecting cattle. The experimental vaccine is based on the use of nanoparticles to present and deliver p67C antigen. In future the vaccine will be de...
| Main Authors: | , , , , |
|---|---|
| Format: | Brief |
| Language: | Inglés |
| Published: |
2022
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10568/126010 |
Similar Items: Improved vaccines for the control of East Coast Fever: IPSR Innovation Profile
- East Coast fever mRNA vaccines – sweetening the promise
- Design and immunological evaluation of two-component protein nanoparticle vaccines for East Coast fever
- An economic assessment of farmer demand in Kenya for a vaccine against East Coast fever
- Production and delivery costs of the infection-and-treatment vaccine against East Coast Fever
- Potential demand estimation of east coast fever vaccines in Makuyu division, Kenya: an application of contingent valuation and conjoint analysis.
- The biology of Theileria parva and control of East Coast fever—Current status and future trends